Tactile Systems Technology Inc. (TCMD)
Tactile Systems Technology Inc. (TCMD) Insider Trading
Directors, officers and holders of more than 10% of TCMD report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 61 transactions on file: 0 with code P, 21 with code S and 29 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Dodd Sheri Louise | Chief Executive Officer | S Sale | 10,978 | $29.44 | $323,243 |
| May 11, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 4,631 | $24.49 | $113,404 |
| May 6, 2026 | Washington Boyd Vindell | Director | A Award | 6,521 | Not measured | Not measured |
| May 6, 2026 | Volkart Carmen B | Director | A Award | 6,521 | Not measured | Not measured |
| May 6, 2026 | Shafer David Brent | Director | A Award | 6,521 | Not measured | Not measured |
| May 6, 2026 | Pearson Andrea | Director | A Award | 6,521 | Not measured | Not measured |
| May 6, 2026 | King Laura G. | Director | A Award | 6,521 | Not measured | Not measured |
| May 6, 2026 | Huggenberger Raymond | Director | A Award | 6,521 | Not measured | Not measured |
| May 6, 2026 | Asbury Valerie L. | Director | A Award | 6,521 | Not measured | Not measured |
| May 6, 2026 | BURKE WILLIAM W | Director | A Award | 6,521 | Not measured | Not measured |
| Mar 9, 2026 | Pearson Andrea | Director | A Award | 852 | Not measured | Not measured |
| Feb 24, 2026 | Dodd Sheri Louise | Chief Executive Officer | S Sale | 10,993 | $28.94 | $318,144 |
| Feb 24, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | S Sale | 6,246 | $28.94 | $180,764 |
| Feb 24, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 7,701 | $28.94 | $222,880 |
| Feb 23, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | S Sale | 160 | $28.69 | $4,590 |
| Feb 23, 2026 | Dodd Sheri Louise | Chief Executive Officer | S Sale | 537 | $28.69 | $15,406 |
| Feb 23, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 196 | $28.69 | $5,623 |
| Feb 23, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 5,322 | $28.28 | $150,521 |
| Feb 23, 2026 | Dodd Sheri Louise | Chief Executive Officer | S Sale | 14,703 | $28.28 | $415,839 |
| Feb 23, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | S Sale | 4,279 | $28.28 | $121,022 |
| Feb 20, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | A Award | 3,579 | Not measured | Not measured |
| Feb 20, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | A Award | 15,575 | Not measured | Not measured |
| Feb 20, 2026 | Dodd Sheri Louise | Chief Executive Officer | A Award | 19,751 | Not measured | Not measured |
| Feb 20, 2026 | Dodd Sheri Louise | Chief Executive Officer | A Award | 28,216 | Not measured | Not measured |
| Feb 20, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | A Award | 3,490 | Not measured | Not measured |
| Feb 20, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | A Award | 4,058 | Not measured | Not measured |
| Feb 20, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | A Award | 7,123 | Not measured | Not measured |
| Feb 20, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | A Award | 6,765 | Not measured | Not measured |
| Feb 19, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | A Award | 6,194 | Not measured | Not measured |
| Feb 19, 2026 | Dodd Sheri Louise | Chief Executive Officer | A Award | 48,672 | Not measured | Not measured |
| Feb 19, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | A Award | 23,008 | Not measured | Not measured |
| Jan 2, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | S Sale | 5,139 | $28.85 | $148,260 |
| Aug 8, 2025 | Dodd Sheri Louise | Chief Executive Officer | S Sale | 7,762 | $12.36 | $95,907 |
| May 12, 2025 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 2,921 | $9.94 | $29,037 |
| May 8, 2025 | BURKE WILLIAM W | Director | S Sale | 3,300 | $9.67 | $31,911 |
| May 8, 2025 | Dodd Sheri Louise | Chief Executive Officer | S Sale | 3,149 | $9.83 | $30,955 |
| May 7, 2025 | Huggenberger Raymond | Director | A Award | 16,078 | Not measured | Not measured |
| May 7, 2025 | Asbury Valerie L. | Director | A Award | 16,078 | Not measured | Not measured |
| May 7, 2025 | Volkart Carmen B | Director | A Award | 16,078 | Not measured | Not measured |
| May 7, 2025 | BURKE WILLIAM W | Director | A Award | 16,078 | Not measured | Not measured |
| May 7, 2025 | Washington Boyd Vindell | Director | A Award | 16,078 | Not measured | Not measured |
| May 7, 2025 | Shafer David Brent | Director | A Award | 16,078 | Not measured | Not measured |
| May 7, 2025 | King Laura G. | Director | A Award | 16,078 | Not measured | Not measured |
| Mar 11, 2025 | REUVERS DANIEL L. | Director | G Gift | 68,162 | Not measured | Not measured |
| Mar 11, 2025 | REUVERS DANIEL L. | Director | G Gift | 68,162 | Not measured | Not measured |
| Feb 25, 2025 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 2,066 | $14.51 | $29,980 |
| Feb 25, 2025 | REUVERS DANIEL L. | Director | S Sale | 28,338 | $14.18 | $401,850 |
| Feb 25, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | S Sale | 6,468 | $14.40 | $93,160 |
| Feb 24, 2025 | REUVERS DANIEL L. | Director | S Sale | 10,938 | $14.55 | $159,147 |
| Feb 24, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | S Sale | 4,830 | $14.65 | $70,753 |
The full Form 4 history is on the TCMD company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.